The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 23359097)

Published in J Thromb Thrombolysis on November 01, 2013

Authors

Marie Méan1, Marc Righini, Kurt Jaeger, Hans-Jürg Beer, Beat Frauchiger, Joseph Osterwalder, Nils Kucher, Bernhard Lämmle, Jacques Cornuz, Anne Angelillo-Scherrer, Nicolas Rodondi, Andreas Limacher, Sven Trelle, Christian M Matter, Marc Husmann, Martin Banyai, Markus Aschwanden, Michael Egloff, Lucia Mazzolai, Olivier Hugli, Henri Bounameaux, Drahomir Aujesky

Author Affiliations

1: Division of General Internal Medicine, Bern University Hospital, Inselspital, 3010, Bern, Switzerland, marie.mean@insel.ch.

Articles by these authors

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med (2010) 9.92

Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65

Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77

Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med (2002) 6.37

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32

Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet (2011) 6.25

Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med (2007) 6.17

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (2010) 5.68

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med (2002) 5.50

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14

Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med (2012) 4.87

Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr (2008) 4.82

Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med (2005) 4.80

Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med (2014) 4.37

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood (2003) 3.88

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med (2009) 3.83

Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med (2006) 3.70

Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet (2008) 3.33

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst (2006) 3.23

Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum (2007) 3.22

Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med (2008) 3.20

Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood (2009) 3.18

Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2007) 3.16

Impending paradoxical embolism: systematic review of prognostic factors and treatment. Chest (2009) 3.09

Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis. Lancet Oncol (2013) 2.99

Pulmonary embolism and deep vein thrombosis. Lancet (2012) 2.97

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ (2010) 2.88

von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood (2010) 2.82

Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med (2003) 2.76

Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J (2005) 2.66

Clustering of risk behaviors with cigarette consumption: A population-based survey. Prev Med (2006) 2.61

[Statin treatment in primary and secondary prevention--a statement]. Rev Med Suisse (2014) 2.55

Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model. JAMA Intern Med (2013) 2.51

Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51

Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA (2012) 2.49

Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43

Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science (2004) 2.38

Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med (2002) 2.37

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest (2011) 2.37

Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33

The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ (2009) 2.29

Prognostic importance of hyponatremia in patients with acute pulmonary embolism. Am J Respir Crit Care Med (2010) 2.26

Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med (2013) 2.25

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24

Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med (2010) 2.23

Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med (2004) 2.22

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J (2013) 2.21

Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation (2004) 2.21

Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med (2011) 2.19

A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med (2006) 2.18

The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med (2004) 2.11

Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med (2010) 2.11

A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One (2008) 2.07

Association of major and minor ECG abnormalities with coronary heart disease events. JAMA (2012) 2.07

Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost (2009) 2.05

Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05

Changes in PESI scores predict mortality in intermediate-risk patients with acute pulmonary embolism. Eur Respir J (2012) 2.03

Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ (2010) 1.99

Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation (2004) 1.97

Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood (2002) 1.93

Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med (2009) 1.91

Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation (2004) 1.90

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA (2005) 1.87

Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica (2007) 1.87

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood (2012) 1.87

Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA (2005) 1.82

Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study. Am J Med (2012) 1.81

From abstract to impact in cardiovascular research: factors predicting publication and citation. Eur Heart J (2012) 1.79

Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care (2009) 1.79

Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation (2012) 1.79

Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. J Bone Miner Res (2006) 1.78

Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum (2007) 1.76